NDAQ vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 15, 2026

NDAQ

57.5
AI Score
VS
CME Wins

CME

64.2
AI Score

Investment Advisor Scores

NDAQ

58score
Recommendation
HOLD

CME

64score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric NDAQ CME Winner
Forward P/E 24.6914 22.9885 CME
PEG Ratio 2.3082 4.7612 NDAQ
Revenue Growth 13.7% 14.4% CME
Earnings Growth 33.8% 21.3% NDAQ
Tradestie Score 57.5/100 64.2/100 CME
Profit Margin 35.3% 63.3% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY CME

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.